In New Court Filing, Illumina Claims Affy Hid Information That Could Invalidate IP | GenomeWeb

Illumina last week filed an amended response to an Affymetrix complaint, responding to allegations of patent infringement by accusing Affy of "inequitable conduct," of having "unclean hands," and of violating federal antitrust legislation, according to court documents.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.